Ruth Matthew R.
Insider CIK 1872022 · OPNT Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 50,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 2,000 | $20.00 | $40.0K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2023-03-02 | 2023-03-03 | 2,000 | — | $0 | 2,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 10,666 | $20.00 | $213.3K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 19,250 | $20.00 | $385.0K | 10,666 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2022-07-20 | 2022-07-21 | 1,084 | $10.62 | $11.5K | 29,916 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-06-27 | 2022-06-29 | 2,000 | — | $0 | 31,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-01-04 | 2022-01-05 | 12,000 | — | $0 | 29,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2021-08-31 | 2021-09-01 | 2,000 | $17.34 | $34.7K | 17,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2021-07-19 | 2021-07-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-07-19 | 2021-07-20 | 15,000 | — | $0 | 15,000 | SEC↗ |